March 19, 2020 – Ringwood, NJ – The Pharma & Biopharma Outsourcing Association (PBOA), a trade group that represents Contract Manufacturing Organizations (CMOs) and other service providers in the bio/pharmaceutical sector, reports that its member companies remain committed to serving patients by manufacturing effective, quality products for their customers, during this global health crisis, and.
1. What trends or market dynamics do you think are challenging contract services providers most these days? The top five end-to-end CDMOs still only comprise 15 percent of the market.1 Beyond these, there are about 300 to 400 others vying for contract work.2 That’s a crowd and makes the process of finding the right contract.
HELP, E&C release discussion draft of User Fees Reauthorization
Talking about the bio/pharma outsourcing industry with Global Business Reports